The Cooper Companies, Inc. (COO)
USD 81.03
(1.43%)
USD 81.03
(1.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.44 Billion USD | -6.73% |
| 2022 | 2.62 Billion USD | 62.57% |
| 2021 | 1.61 Billion USD | -15.64% |
| 2020 | 1.91 Billion USD | 10.18% |
| 2019 | 1.73 Billion USD | -10.68% |
| 2018 | 1.94 Billion USD | 79.45% |
| 2017 | 1.08 Billion USD | -12.09% |
| 2016 | 1.23 Billion USD | -7.54% |
| 2015 | 1.33 Billion USD | -1.74% |
| 2014 | 1.35 Billion USD | 407.79% |
| 2013 | 267.26 Million USD | -25.94% |
| 2012 | 360.86 Million USD | -3.83% |
| 2011 | 375.25 Million USD | -38.24% |
| 2010 | 607.56 Million USD | -21.86% |
| 2009 | 777.54 Million USD | -13.88% |
| 2008 | 902.85 Million USD | 3.37% |
| 2007 | 873.4 Million USD | 18.92% |
| 2006 | 734.42 Million USD | 8.95% |
| 2005 | 674.08 Million USD | 433.43% |
| 2004 | 126.36 Million USD | -8.71% |
| 2003 | 138.42 Million USD | -9.76% |
| 2002 | 153.39 Million USD | 174.54% |
| 2001 | 55.87 Million USD | 65.59% |
| 2000 | 33.74 Million USD | -17.9% |
| 1999 | 41.1 Million USD | -50.48% |
| 1998 | 83 Million USD | 1054.02% |
| 1997 | -8.7 Million USD | -120.76% |
| 1996 | 41.9 Million USD | 18.03% |
| 1995 | 35.5 Million USD | -4.83% |
| 1994 | 37.3 Million USD | -14.84% |
| 1993 | 43.8 Million USD | 70.43% |
| 1992 | 25.7 Million USD | 195.54% |
| 1991 | -26.9 Million USD | 73.21% |
| 1990 | -100.4 Million USD | -8.42% |
| 1989 | -92.6 Million USD | -114.6% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 2.52 Billion USD | -2.99% |
| 2024 Q1 | 2.63 Billion USD | 7.7% |
| 2024 Q2 | 2.6 Billion USD | -1.39% |
| 2023 FY | 2.44 Billion USD | -6.73% |
| 2023 Q3 | 2.47 Billion USD | -2.03% |
| 2023 Q2 | 2.52 Billion USD | -1.9% |
| 2023 Q1 | 2.57 Billion USD | -1.83% |
| 2023 Q4 | 2.44 Billion USD | -1.15% |
| 2022 Q2 | 3.07 Billion USD | -4.34% |
| 2022 Q4 | 2.62 Billion USD | -7.91% |
| 2022 FY | 2.62 Billion USD | 62.57% |
| 2022 Q1 | 3.21 Billion USD | 99.33% |
| 2022 Q3 | 2.85 Billion USD | -7.42% |
| 2021 Q3 | 1.74 Billion USD | -6.84% |
| 2021 Q4 | 1.61 Billion USD | -7.43% |
| 2021 Q2 | 1.87 Billion USD | -3.55% |
| 2021 Q1 | 1.94 Billion USD | 1.43% |
| 2021 FY | 1.61 Billion USD | -15.64% |
| 2020 FY | 1.91 Billion USD | 10.18% |
| 2020 Q4 | 1.91 Billion USD | -3.79% |
| 2020 Q3 | 1.98 Billion USD | -3.05% |
| 2020 Q1 | 1.94 Billion USD | 11.73% |
| 2020 Q2 | 2.05 Billion USD | 5.72% |
| 2019 Q2 | 1.82 Billion USD | -8.23% |
| 2019 Q3 | 1.69 Billion USD | -6.72% |
| 2019 FY | 1.73 Billion USD | -10.68% |
| 2019 Q4 | 1.73 Billion USD | 2.2% |
| 2019 Q1 | 1.98 Billion USD | 2.09% |
| 2018 FY | 1.94 Billion USD | 79.45% |
| 2018 Q2 | 2.31 Billion USD | 0.35% |
| 2018 Q3 | 2.13 Billion USD | -7.77% |
| 2018 Q4 | 1.94 Billion USD | -9.05% |
| 2018 Q1 | 2.31 Billion USD | 113.19% |
| 2017 Q1 | 1.33 Billion USD | 8.15% |
| 2017 Q3 | 1.16 Billion USD | -7.76% |
| 2017 Q4 | 1.08 Billion USD | -7.15% |
| 2017 FY | 1.08 Billion USD | -12.09% |
| 2017 Q2 | 1.26 Billion USD | -5.08% |
| 2016 FY | 1.23 Billion USD | -7.54% |
| 2016 Q4 | 1.23 Billion USD | -10.75% |
| 2016 Q3 | 1.38 Billion USD | -1.11% |
| 2016 Q2 | 1.39 Billion USD | 2.62% |
| 2016 Q1 | 1.36 Billion USD | 2.08% |
| 2015 Q1 | 1.37 Billion USD | 1.6% |
| 2015 Q4 | 1.33 Billion USD | 3.31% |
| 2015 Q3 | 1.29 Billion USD | -2.93% |
| 2015 Q2 | 1.32 Billion USD | -3.56% |
| 2015 FY | 1.33 Billion USD | -1.74% |
| 2014 Q3 | 174.15 Million USD | -31.1% |
| 2014 Q2 | 252.76 Million USD | -20.24% |
| 2014 Q1 | 316.9 Million USD | 18.57% |
| 2014 Q4 | 1.35 Billion USD | 679.27% |
| 2014 FY | 1.35 Billion USD | 407.79% |
| 2013 Q2 | 306.06 Million USD | -22.23% |
| 2013 Q4 | 267.26 Million USD | 22.52% |
| 2013 Q3 | 218.14 Million USD | -28.72% |
| 2013 FY | 267.26 Million USD | -25.94% |
| 2013 Q1 | 393.52 Million USD | 9.05% |
| 2012 Q2 | 311.56 Million USD | -22.62% |
| 2012 Q1 | 402.62 Million USD | 7.29% |
| 2012 Q4 | 360.86 Million USD | -22.78% |
| 2012 FY | 360.86 Million USD | -3.83% |
| 2012 Q3 | 467.35 Million USD | 50.0% |
| 2011 Q3 | 437.34 Million USD | -19.72% |
| 2011 FY | 375.25 Million USD | -38.24% |
| 2011 Q4 | 375.25 Million USD | -14.2% |
| 2011 Q1 | 598.89 Million USD | -1.43% |
| 2011 Q2 | 544.78 Million USD | -9.03% |
| 2010 Q1 | 741.49 Million USD | -4.64% |
| 2010 Q3 | 643.43 Million USD | -8.49% |
| 2010 Q4 | 607.56 Million USD | -5.57% |
| 2010 Q2 | 703.11 Million USD | -5.18% |
| 2010 FY | 607.56 Million USD | -21.86% |
| 2009 Q1 | 911.27 Million USD | 0.93% |
| 2009 Q2 | 891.12 Million USD | -2.21% |
| 2009 FY | 777.54 Million USD | -13.88% |
| 2009 Q4 | 777.54 Million USD | -6.9% |
| 2009 Q3 | 835.18 Million USD | -6.28% |
| 2008 Q2 | 939.13 Million USD | 1.8% |
| 2008 FY | 902.85 Million USD | 3.37% |
| 2008 Q1 | 922.52 Million USD | 5.62% |
| 2008 Q4 | 902.85 Million USD | -2.32% |
| 2008 Q3 | 924.32 Million USD | -1.58% |
| 2007 Q1 | 830.11 Million USD | 13.03% |
| 2007 FY | 873.4 Million USD | 18.92% |
| 2007 Q4 | 873.4 Million USD | 2.37% |
| 2007 Q3 | 853.22 Million USD | -0.07% |
| 2007 Q2 | 853.83 Million USD | 2.86% |
| 2006 Q1 | 741.17 Million USD | 9.95% |
| 2006 FY | 734.42 Million USD | 8.95% |
| 2006 Q2 | 740.25 Million USD | -0.12% |
| 2006 Q3 | 746.29 Million USD | 0.82% |
| 2006 Q4 | 734.42 Million USD | -1.59% |
| 2005 Q2 | 702.5 Million USD | -1.92% |
| 2005 FY | 674.08 Million USD | 433.43% |
| 2005 Q3 | 705.69 Million USD | 0.45% |
| 2005 Q4 | 674.08 Million USD | -4.48% |
| 2005 Q1 | 716.27 Million USD | 466.82% |
| 2004 Q4 | 126.36 Million USD | -12.46% |
| 2004 FY | 126.36 Million USD | -8.71% |
| 2004 Q3 | 144.35 Million USD | -8.65% |
| 2004 Q2 | 158.01 Million USD | 15.57% |
| 2004 Q1 | 136.73 Million USD | -1.23% |
| 2003 Q4 | 138.42 Million USD | -14.02% |
| 2003 Q2 | 150.68 Million USD | -9.93% |
| 2003 Q3 | 161 Million USD | 6.85% |
| 2003 FY | 138.42 Million USD | -9.76% |
| 2003 Q1 | 167.3 Million USD | 9.06% |
| 2002 Q1 | 59.04 Million USD | 5.68% |
| 2002 FY | 153.39 Million USD | 174.54% |
| 2002 Q4 | 153.39 Million USD | -3.82% |
| 2002 Q3 | 159.49 Million USD | 8.11% |
| 2002 Q2 | 147.52 Million USD | 149.84% |
| 2001 Q2 | 39.94 Million USD | 30.16% |
| 2001 Q4 | 55.87 Million USD | 27.68% |
| 2001 Q3 | 43.76 Million USD | 9.55% |
| 2001 Q1 | 30.68 Million USD | -9.05% |
| 2001 FY | 55.87 Million USD | 65.59% |
| 2000 FY | 33.74 Million USD | -17.9% |
| 2000 Q4 | 33.74 Million USD | -13.23% |
| 2000 Q1 | 57.3 Million USD | 39.42% |
| 2000 Q2 | 49.75 Million USD | -13.16% |
| 2000 Q3 | 38.88 Million USD | -21.84% |
| 1999 Q3 | 47.8 Million USD | -13.09% |
| 1999 Q2 | 55 Million USD | -26.86% |
| 1999 FY | 41.1 Million USD | -50.48% |
| 1999 Q4 | 41.1 Million USD | -14.02% |
| 1999 Q1 | 75.2 Million USD | -9.4% |
| 1998 Q1 | 56.5 Million USD | 749.43% |
| 1998 FY | 83 Million USD | 1054.02% |
| 1998 Q4 | 83 Million USD | 20.29% |
| 1998 Q3 | 69 Million USD | -1.43% |
| 1998 Q2 | 70 Million USD | 23.89% |
| 1997 Q3 | -100 Thousand USD | -100.19% |
| 1997 Q4 | -8.7 Million USD | -8600.0% |
| 1997 Q2 | 51.4 Million USD | 8.44% |
| 1997 Q1 | 47.4 Million USD | 13.13% |
| 1997 FY | -8.7 Million USD | -120.76% |
| 1996 Q4 | 41.9 Million USD | -10.09% |
| 1996 Q3 | 46.6 Million USD | -8.09% |
| 1996 FY | 41.9 Million USD | 18.03% |
| 1996 Q1 | 43.4 Million USD | 22.25% |
| 1996 Q2 | 50.7 Million USD | 16.82% |
| 1995 Q3 | 40 Million USD | -7.62% |
| 1995 Q4 | 35.5 Million USD | -11.25% |
| 1995 Q1 | 42.2 Million USD | 13.14% |
| 1995 FY | 35.5 Million USD | -4.83% |
| 1995 Q2 | 43.3 Million USD | 2.61% |
| 1994 Q3 | 38.5 Million USD | 41.03% |
| 1994 Q2 | 27.3 Million USD | -36.95% |
| 1994 Q4 | 37.3 Million USD | -3.12% |
| 1994 Q1 | 43.3 Million USD | -1.14% |
| 1994 FY | 37.3 Million USD | -14.84% |
| 1993 Q4 | 43.8 Million USD | 8.96% |
| 1993 Q2 | 30.9 Million USD | 21.65% |
| 1993 FY | 43.8 Million USD | 70.43% |
| 1993 Q3 | 40.2 Million USD | 30.1% |
| 1993 Q1 | 25.4 Million USD | -1.17% |
| 1992 Q2 | 17.8 Million USD | 304.6% |
| 1992 FY | 25.7 Million USD | 195.54% |
| 1992 Q4 | 25.7 Million USD | -11.38% |
| 1992 Q1 | -8.7 Million USD | 67.66% |
| 1992 Q3 | 29 Million USD | 62.92% |
| 1991 Q4 | -26.9 Million USD | -124.17% |
| 1991 Q3 | -12 Million USD | 82.91% |
| 1991 Q2 | -70.2 Million USD | -10.73% |
| 1991 Q1 | -63.4 Million USD | 36.85% |
| 1991 FY | -26.9 Million USD | 73.21% |
| 1990 FY | -100.4 Million USD | -8.42% |
| 1990 Q4 | -100.4 Million USD | 0.0% |
| 1989 FY | -92.6 Million USD | -114.6% |
| 1989 Q4 | -92.6 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -94762.456% |
| AngioDynamics, Inc. | -70.14 Million USD | 3590.633% |
| AtriCure, Inc. | -9.81 Million USD | 25042.95% |
| Avinger, Inc. | 10.12 Million USD | -24093.676% |
| Azenta, Inc. | -618.47 Million USD | 495.878% |
| BioLife Solutions, Inc. | 7.25 Million USD | -33657.066% |
| Daxor Corporation | 755.65 Thousand USD | -323908.581% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 166657.823% |
| Femasys Inc. | -15.01 Million USD | 16406.149% |
| GlucoTrack, Inc. | -4.29 Million USD | 57092.551% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -6261.133% |
| Hologic, Inc. | 374.4 Million USD | -553.953% |
| ICU Medical, Inc. | 1.45 Billion USD | -68.798% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 192.035% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 34892.642% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 47421.221% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 57206.245% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 57206.245% |
| Masimo Corporation | 804 Million USD | -204.527% |
| Microbot Medical Inc. | -2.28 Million USD | 107204.112% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 25615.479% |
| Merit Medical Systems, Inc. | 302.22 Million USD | -710.13% |
| Nephros, Inc. | -2.47 Million USD | 99185.391% |
| NovoCure Limited | 355.42 Million USD | -588.873% |
| NEXGEL, Inc. | 98 Thousand USD | -2498267.347% |
| NEXGEL, Inc. | 98 Thousand USD | -2498267.347% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | -4045.966% |
| OraSure Technologies, Inc. | -276.9 Million USD | 984.209% |
| Pro-Dex, Inc. | 10.91 Million USD | -22329.461% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 7051.535% |
| Predictive Oncology Inc. | -5.87 Million USD | 41797.279% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -80727.074% |
| QuidelOrtho Corporation | 2.49 Billion USD | 1.876% |
| Repligen Corporation | -39.51 Million USD | 6295.501% |
| Sanara MedTech Inc. | 6.64 Million USD | -36746.336% |
| STAAR Surgical Company | -147.2 Million USD | 1763.27% |
| Sharps Technology, Inc. | -3.01 Million USD | 81363.683% |
| Utah Medical Products, Inc. | -92.52 Million USD | 2746.175% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | -24.601% |
| Jin Medical International Ltd. | -2.81 Million USD | 87030.341% |